EVAR- MORE GOOD NEWS OUT!!
IRVINE, Calif. , Feb. 24, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc.
(NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of
abdominal aortic aneurysms (AAAs), today announced that the first commercial
procedure in Germany using the revolutionary new Altura® Endovascular Stent
Graft was successfully completed at the Saarland University Medical
Center-Clinic for Diagnostic and Interventional Radiology following the late
January Leipzig Interventional Course (LINC) in Leipzig , Germany. The hospital
is a major EVAR center in the state of Saarland, Germany .
“We are honored to be the first German center to complete an Altura EVAR
procedure following last month’s LINC meeting and have additional cases
scheduled in the coming weeks,” said Dr. Alexander Massmann , Saarland University
Medical Center . “We found the new Altura stent graft from Lombard easy to use,
with a minimal amount of steps required to implant the stent graft. We were
especially impressed with the 14F ultra low profile design and the elimination
of the gate cannulation step which can be a real procedural time saver.”
“We have been pleased with the interest and uptake of our new Altura stent graft
following a successful LINC meeting in January,” said Lombard CEO Simon Hubbert .
“We are already receiving positive feedback from physicians in the UK and
Germany regarding the unique features of Altura that deliver a simplified, more
accurate and faster EVAR procedure than currently available stent grafts
treating mainstream AAA anatomy. We’d like to thank Dr. Massmann and Univ. Prof.
Dr. Arno Bücker M.Sc., for this opportunity.”
